The Au‐AR pep‐PROTAC Drug Induces AR and AR‐V7 Degradation, Inhibits the Proliferation of both AR‐ and AR‐V7‐Positive Prostate Cancer Cells. This evidence concerns the gene AR and Familial prostate cancer.